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Abstract: The development of artificial nanomotor systems
that are stimuli-responsive is still posing many challenges.
Herein, we demonstrate the self-assembly of a redox-respon-
sive stomatocyte nanomotor system, which can be used for
triggered drug release under biological reducing conditions.
The redox sensitivity was introduced by incorporating a disul-
fide bridge between the hydrophilic poly(ethylene glycol)
block and the hydrophobic polystyrene block. When incubated
with the endogenous reducing agent glutathione at a concen-
tration comparable to that within cells, the external PEG shells
of these stimuli-responsive nanomotors are cleaved. The
specific bowl-shaped stomatocytes aggregate after the treat-
ment with glutathione, leading to the loss of motion and
triggered drug release. These novel redox-responsive nano-
motors can not only be used for remote transport but also for
drug delivery, which is promising for future biomedical
applications.
In nature, organisms are capable of complex motion behavior
in response to environmental changes to achieve different
functions.[1] To mimic this fantastic self-migrating behavior
from nature, artificial centimeter-scale motors (hemicylindri-
cal plates) were first reported by Whitesides and co-workers
with platinum on one side of the surface.[2] These plates were
propelled by oxygen bubbles that were generated by plati-
num-catalyzed decomposition of a hydrogen peroxide (H2O2)
solution. After a decadeQs effort, synthetic self-propelled
motors with miniature size were rapidly developed over the
last few years.[3] Owing to their small size, micro- and
nanomotors show huge potential in different ranges of
applications, such as environmental remediation, sensing,
assisted fertilization, and drug delivery.[4]
Compared to normal drug delivery systems, the most
important advantage of micro- and nanomotor systems is the
impetus that is independent from the blood flow, which is
necessary for tissue penetration and crossing cellular bar-
riers.[4d] Therefore, to develop the next generation of drug
delivery systems, both propulsion and in-site drug release are
important aspects for the design of active and directional
delivery systems. Although some studies on artificial self-
propelled motors towards drug delivery applications have
been reported, most of them either have micrometer dimen-
sions or low drug loading efficiencies or cannot undergo
controlled release of the loaded drug, which is not very
practical for drug delivery.[5] Therefore, nanomotor systems
that can sense different stimuli produced by cells to control
the properties and achieve transport behavior are a promising
and also important research field. Recently, calcium carbon-
ate Janus microparticles were reported that can move under
extremely weakly acidic conditions generated by HeLa cells
in situ.[6] However, the development of nanomotors that are
capable of controlled drug release is still challenging.
To achieve in-site drug release, the specific environment
and the differences between the desired and non-desired sites
of release should be taken into account. For example, the
human body hosts many gradients of chemical signaling
molecules, resulting in pH differences for inflamed, infected,
or tumor tissue or even in different compartments of the cells.
Temperature fluctuations can be observed at specific patho-
logical sites, and redox potentials exist between extracellular
and intracellular microenvironments.[7] With regard to the
latter, the intracellular compartments possess a much higher
glutathione concentration (GSH, 2–10 mm) than the extra-
cellular microenvironment (2–10 mm), which can be used as
a trigger to achieve controlled release of encapsulated
molecules from nanocarrier systems.[8] Aside from the differ-
ences in the physiological oxidative conditions between
extracellular and intracellular compartments, pathophysio-
logical oxidative aspects in inflamed or tumor tissues can also
be exploited to destabilize the drug delivery systems.
In our previous work, platinum nanoparticles (PtNPs)
were loaded into the cavity of bowl-shaped stomatocyte
nanomotors that self-assembled from the block copolymer
poly(ethylene glycol)-b-polystyrene (PEG-b-PS).[9] It was
demonstrated that the motion[3l] of these polymeric nano-
motors can be controlled and that they can also be guided[3n]
and steered[10] in desired directions in the presence of H2O2
and alternative biofuels.[11] However, owing to the glassy and
compact PS bilayer structure, the nanomotor cannot be
degraded, and therefore, the loaded drugs were trapped
either in the hydrophobic membrane or in the hydrophilic
lumen, which is not suitable for further biomedical applica-
tions. Herein, we demonstrate the successful design of a first
redox-responsive nanomotor system through the incorpora-
tion of disulfide bonds between the hydrophobic PS block and
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the hydrophilic PEG block (PEG-SS-PS). After the intro-
duction of disulfide bonds, the morphology of the bowl-
shaped structure and the encapsulation of model PtNP
catalysts remained the same. The multifunctional nanomotor
systems are able to probe the environment by sensing
a change in the outside redox conditions, which leads to the
cleavage of the hydrophilic PEG part and further disables the
motion function. In human bodies, tumor tissues can produce
H2O2 gradients owing to their high production rate of up to
5 nmol per 104 cells per hour, which is not too low when
related to the size of a tumor.[12] Our redox-sensitive nano-
motors can follow the resulting H2O2 gradient in the body and
move towards to the diseased area.[3n]After accumulation, the
redox-responsive nanomotors can be taken up and release the
loaded drug owing to the higher intracellular GSH concen-
tration. In addition, the higher concentration of GSH also
results in inhibition of the motion behavior owing to catalyst
poisoning by the thiol group in GSH.[13] These multifunctional
bioreducible nanomotor systems can potentially lead to a new
approach for a more efficient and controlled way to deliver
drugs in the future.
The redox-sensitive block copolymer PEG-SS-PS (Fig-
ure 1a) and the standard polymer PEG-b-PS were synthe-
sized by atom transfer radical polymerization (ATRP) of
styrene by starting from PEG-SS-Br and PEG-Br macro-
initiators, respectively (see the Supporting Information,
Scheme S1).[14] After determination of the average molecular
weight of PEG-SS-PS and PEG-b-PS by 1H NMR spectros-
copy, redox-sensitive polymersomes were then self-assembled
by a solvent switch method (Figure 1b). During the self-
assembly, the hydrophilic anticancer drug doxorubicin (Dox)
was loaded into the lumen of the polymersomes. In the
presence of an organic solvent, the formed polymersomes
with a flexible membrane underwent a morphology change
into bowl-shaped stomatocyte structures owing to an osmotic
shock introduced by dialysis.[15] During the shape trans-
formation, model catalysts, namely PtNPs, were entrapped in
the cavities of the stomatocytes to serve as engines for the
nanomotors (Figure 1b). After dialysis to remove the organic
solvent, Dox-loaded redox-responsive nanomotors and
redox-insensitive nanomotors were obtained. According to
dynamic light scattering (DLS) analysis, the self-assembled
structures have similar sizes and also a narrow polydispersity
index (PDI; Table S1). Transmission electron microscopy
(TEM) was further used to visualize the structure of the
stomatocyte nanomotors. Well-defined stomatocytes with
a clear bilayer structure and also PtNP encapsulation were
observed for both redox-sensitive and -insensitive nanomotor
samples (Figures 2a and S1), indicating that the introduction
of the disulfide bond does not affect the formation of the
polymeric vesicles.
The redox-sensitive nature of the disulfide bond between
the two blocks was exploited by addition of the endogenous
reducing agent GSH. TEM and scanning electron microscopy
(SEM) were used to observe the morphology changes of the
nanomotor structures before and after incubation with GSH.
Before addition of GSH, regular stomatocytes with small
openings were observed in both TEM and SEM images
(Figure 2a, c) while aggregation without a clear bilayer
membrane was observed after overnight treatment with
GSH (Figure 2b,d). The small GSH molecules can enter
through the PEG shell of the nanomotor and then break down
the redox-responsive disulfide bonds that covalently link the
PEG and PS blocks, resulting in cleavage of the outside PEG
shell. The resulting structures are hydrophobic and unstable
owing to the loss of the hydrophilic PEG layer, which
therefore leads to the formation of aggregates, as observed in
the TEM and SEM images.
To confirm the structural changes of redox-responsive
stomatocytes induced by GSH, DLS was also used to measure
the size before and after incubation with the reducing agent
for both sensitive and insensitive stomatocytes. For the
insensitive stomatocytes, the sizes remained almost the same
(diameter ca. 345 nm) after treatment with GSH, even when
the concentration of the reducing agent was increased to
120 mm (Figure S3a). The intensity DLS curve showed
Figure 1. a) Chemical structure of the redox-responsive block copoly-
mer PEG-SS-PS used for the stomatocyte assembly. b) Self-assembly
and GSH-triggered disassembly of the redox-sensitive stomatocyte
nanomotor.
Figure 2. Characterization of the redox-sensitive stomatocyte nanomo-
tor before and after incubation with GSH. a) TEM image of a stomato-
cyte nanomotor. b) TEM image of a stomatocyte nanomotor after
incubation with GSH. c) SEM image of a stomatocyte nanomotor.
d) SEM image of a stomatocyte nanomotor after treatment with GSH.
Scale bars: 200 nm.
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a narrow distribution, which was further confirmed by the low
PDI (Supplementary Table 2). For stomatocytes composed of
the stimuli-responsive polymer PEG-SS-PS, the size distribu-
tion underwent a significant shift. The particle size changed
from 349 nm to 1392 nm after treatment with 20 mm GSH
(Figure S3b and Table S2), indicating the formation of
aggregates, which was also confirmed by TEM and SEM
(Figure 2b,d). Similar behavior was observed for GSH at
concentrations of 40 mm and 120 mm. The size and count rate
of the redox stomatocytes were also measured during the
treatment with GSH (Figure S4). The size increased gradually
with the GSH incubation time while the count rate decreased
accordingly. Furthermore, the zeta potential of the redox
stomatocytes before and after incubation with GSH was
measured (Table S3). After treatment with GSH, the zeta
potential of the redox-sensitive stomatocytes had changed
from @30.9 mV to @45.2 mV, again indicating PEG cleavage.
To confirm the successful PEG cleavage from the redox-
responsive stomatocytes, diffusion NMR spectroscopy was
used to measure the diffusion coefficient of the cleaved PEG
after incubation of the redox-sensitive sample with GSH and
to compare it with that of free PEG polymer (2 kDa, the same
molecular weight as the PEG part of PEG-SS-PS). After
GSH-triggered PEG cleavage, the resulting sample was
centrifuged to obtain the supernatant, which contains the
cleaved PEG and GSH. The supernatant was then freeze-
dried and redissolved in deuterium oxide (D2O). GSH
resonances were observed at d= 3.88 (2H, NHCH2COOH)
and 3.73 ppm (1H, CH2CHNH2COOH; Figure S5a). Specific
PEG signals around d= 3.63 ppm (broad singlet, PEG back-
bone) and 3.31 ppm (singlet, 3H, CH3OCH2) were observed
for both cleaved PEG and free PEG (Figure S5a, c). After
fitting the decay curve of the NMR intensity, the diffusion
coefficient of the cleaved PEG was determined to be 2.76:
0.47X 10@6 cm2 s@1 (Figure S5b). For the free PEG sample, the
diffusion coefficient in D2O was determined to be 2.55:
0.05X 10@6 cm2 s@1 (Figure S5d). As the diffusion coefficient
of the PEG cleaved from the redox-responsive stomatocytes
was almost the same as that of the free PEG control, this is an
another clear indication that the external PEG shell was
indeed cleaved by a GSH-triggered chemical reaction.
As the cleavage of the PEG shells could disassemble the
entire nanomotor system, stimuli-triggered drug release
might be possible. The Dox-loaded redox-sensitive nano-
motors were incubated at different GSH concentrations at
room temperature in vitro. Without GSH treatment, almost
no Dox release was observed for the sensitive nanomotors
(Figure S6). Incubation of the motor solution with 20 mm
GSH, which is comparable to the intracellular concentration,
resulted in a cumulative release of 68% Dox from our
bioreducible nanomotors. This release is significantly higher
than the release in 1 mm GSH.
Having confirmed the redox responsiveness and potential
in vitro drug release, nanoparticle tracking analysis (NTA)
was used to investigate the motion behavior of these nano-
motors in the presence of H2O2 solution. Nanosight NS500
was used to record the movement of the nanomotors in real
time in a video. The movement of the nanomotors was
recorded for 90 s with 30 frames per second. H2O2 solution
was added to the nanomotors, and the resulting solutions were
studied at 30 and 37 8C (final nanomotor concentration:
108 particlesmL@1, final H2O2 concentration: 4.98 mm). The
mean square displacement (MSD) was extracted from the
simultaneous recording of the x,y coordinates of multiple
particles (20 particles) by the NTA technique. Fitting of the
MSD curves allowed for a calculation of the average velocity
of the nanomotors by using the self-diffusiophoretic model
proposed by Golestanian and co-workers.[16] The MSDs
(Figure 3a) and velocities (Figure 3b) of the redox-respon-
sive nanomotors at both 30 and 37 8C show directional
autonomous movement as demonstrated in our previous
studies.[9] Higher MSDs and velocities were observed at 37 8C
than at 30 8C owing to the higher catalytic efficiency of the
PtNPs. However, almost Brownian motion was observed after
treatment with GSH. The MSD curve had a typical shape
(linear) and size for Brownian motion (Figure 3a), which was
similar to the behavior of the nanomotors in the absence of
H2O2 fuel. In the presence of the GSH reducing agent, the
PEG shell was cleaved, destabilizing the self-assembled
structure. In addition, the hydrophobicity of the resulting
system led to further aggregation. Representative tracking
trajectories of redox-responsive nanomotors before and after
the addition of GSH are presented in Figure 3c. The
trajectories of the sensitive nanomotors after degradation
exhibited Brownian motion as expected while directional
motion was observed before incubation with GSH, indicating
active self-propulsion.
Directionality was also used for the characterization of the
motion behavior of our multifunctional nanomotors.[17] The
directionality was calculated by comparing the Euclidian
Figure 3. Motion evaluation of the redox-sensitive stomatocyte nano-
motor. a) MSD of redox-sensitive nanomotors before and after degra-
dation at different temperatures in the presence of H2O2. b) Velocity of
redox-sensitive nanomotors before and after degradation at different
temperatures in the presence of H2O2. The respective velocities were
calculated by fitting with MSD. The directional motion was fitted using
the equation (4D)Dt+ (v2)(Dt2), and the Brownian motion was fitted
using the equation (4D)Dt. Error bars indicate the standard deviation
of the velocity of 20 motors. c) Trajectories of redox-sensitive nano-
motors. d) Directionality of the movement of redox-sensitive nano-
motors as the average of 20 motors. SS-Sto= redox-sensitive nano-
motor.
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distance to the accumulated distance over a certain time
interval. Here, the value of the directionality over a long time
interval (around 1 s) was used to distinguish between non-
Brownian and Brownian motion (Figure 3d). For the sensi-
tive nanomotors in H2O2 at 30 8C, the directionality was
calculated to be 0.690, indicating directional non-Brownian
motion. However, the directionality calculated at 30 8C was
only 0.159 (demonstrated to be Brownian motion) when the
sensitive nanomotors were dismantled by GSH, further
confirming that our sensitive nanomotors lost their motility
after cleavage of the PEG shell.
HeLa cells were used to demonstrate the cellular internal-
ization and release behavior of the redox-responsive nano-
motors. The cells were incubated with Dox-loaded redox-
sensitive or -insensitive nanomotors in the presence of H2O2.
For the bioreducible nanomotors (Figure 4b), the fluores-
cence signal from Dox diffused over the Hela cells, indicating
the triggered release of Dox owing to the higher intracellular
GSH concentration.[18] However, for the insensitive nano-
motors (Figure 4a), dot-like fluorescence signals was
observed, which meant that Dox was still localized within
the nanomotors even after they had been taken up by the
cells.
In summary, we have designed a multifunctional self-
propelled stomatocyte nanomotor with redox-responsive
behavior by introducing a disulfide bridge between the
hydrophobic and hydrophilic blocks of the block copolymer
constituents. Owing to the redox sensitivity of the disulfide
bonds, the reducing agent GSH could be used to degrade the
sensitive nanomotor system at physiological concentrations.
Our nanomotor system is able to sense its local environment,
in this case, the presence of reducing agents, which cleave the
external PEG shell, thereby disabling the motion behavior
and triggering drug release. As an endogenous reducing
agent, GSH is commonly found at higher concentrations in
intracellular compartments than in extracellular compart-
ments, which makes our redox-responsive nanomotor prom-
ising for drug delivery applications in the future.
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